Markus Anton Schirmer

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Venues

Cancers

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

David Alexander Ziegler, Cecilia Christiane Cleve, Sonia Ziegler, Markus Anton Schirmer, Laura Anna Fischer, Hanibal Bohnenberger, Tobias Raphael Overbeck, Friederike Braulke, Alexander von Hammerstein-Equord, Martin Leu, Manuel Guhlich, Leif Hendrik Dröge, Stefan Rieken, Achim Rittmeyer, Rami A El Shafie
Therapeutic Patterns and Clinical Outcomes in Limited Disease Small Cell Lung Cancer: A Decade of Analysis at a Tertiary Cancer Center. Cancers 16 (11) (2024)
David Alexander Ziegler, Cecilia Christiane Cleve, Sonia Ziegler, Markus Anton Schirmer, Laura Anna Fischer, Hanibal Bohnenberger, Tobias Raphael Overbeck, Friederike Braulke, Alexander von Hammerstein-Equord, Martin Leu, Manuel Guhlich, Leif Hendrik Dröge, Stefan Rieken, Achim Rittmeyer, Rami A El Shafie
Therapeutic Patterns and Clinical Outcomes in Limited Disease Small Cell Lung Cancer: A Decade of Analysis at a Tertiary Cancer Center. Cancers 16 (11) (2024)
Felix-Nikolai Oschinka Jegor Habermann, Daniela Schmitt, Thomas Failing, Jann Fischer, David Alexander Ziegler, Laura Anna Fischer, Niklas Josua Alt, Julian Muster, Sandra Donath, Andrea Hille, Markus Anton Schirmer, Manuel Guhlich, Rami A El Shafie, Stefan Rieken, Martin Leu, Leif Hendrik Dröge
Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes. Current oncology (Toronto, Ont.) 29 (2) (2022)
Jacqueline Possiel, Hanne Elisabeth Ammon, Manuel Guhlich, Lena-Christin Conradi, Michael Ghadimi, Hendrik Andreas Wolff, Markus Anton Schirmer, Stephan Samel, Michael Mügge, Stefan Rieken, Martin Leu, Leif Hendrik Dröge
Volumetric Modulated Arc Therapy Improves Outcomes in Definitive Radiochemotherapy for Anal Cancer Whilst Reducing Acute Toxicities and Increasing Treatment Compliance. Cancers 13 (11) (2021)
Leif Hendrik Dröge, Philipp Johannes Karras, Manuel Guhlich, Markus Anton Schirmer, Michael Ghadimi, Stefan Rieken, Lena-Christin Conradi, Martin Leu
Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities. Cancers 13 (8) (2021)
Martin Leu, Christoph Patzer, Manuel Guhlich, Jacqueline Possiel, Yiannis Pilavakis, Markus Anton Schirmer, Stefan Rieken, Leif Hendrik Dröge
Postoperative Radiochemotherapy Using Modern Radiotherapy Techniques in Elderly Patients with Head and Neck Squamous Cell Carcinoma: The Challenge of Weighing Up Benefits and Harms of Treatment Modalities in Clinical Practice. Cancers 13 (14) (2021)
Manuel Guhlich, Laura Hubert, Caroline Patricia Nadine Mergler, Margret Rave-Fraenk, Leif Hendrik Dröge, Martin Leu, Heinz Schmidberger, Stefan Rieken, Andrea Hille, Markus Anton Schirmer
Identification of Risk Loci for Radiotoxicity in Prostate Cancer by Comprehensive Genotyping of TGFB1 and TGFBR1. Cancers 13 (21) (2021)
Martin Leu, Theresa Riebeling, Leif Hendrik Dröge, Laura Hubert, Manuel Guhlich, Hendrik Andreas Wolff, Jürgen Brockmöller, Jochen Gaedcke, Stefan Rieken, Markus Anton Schirmer
8-Oxoguanine DNA Glycosylase (OGG1) Cys326 Variant: Increased Risk for Worse Outcome of Patients with Locally Advanced Rectal Cancer after Multimodal Therapy. Cancers 13 (11) (2021)

Markus Anton Schirmer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Markus Anton Schirmer